Comparison between Influx Healthtech IPO and Taurian MPS IPO.
Influx Healthtech IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Taurian MPS IPO is a SME Bookbuilding proposed to list at NSE SME.
| Influx Healthtech IPO | Taurian MPS IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Rarever Financial Advisors Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | R.K.Stock Holding Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Influx Healthtech IPO is up to ₹55.63 Cr whereas the issue size of the Taurian MPS IPO is up to ₹37.41 Cr. The final issue price of Influx Healthtech IPO is ₹96.00 per share and of Taurian MPS IPO is ₹171.00 per share.
| Influx Healthtech IPO | Taurian MPS IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | ₹162.00 per share |
| Issue Price (Upper) | ₹96.00 per share | ₹171.00 per share |
| Issue Price (Final) | ₹96.00 per share | ₹171.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1200 shares | 800 shares |
| Fresh Issue Size | 46,94,400 shares | 21,88,000 shares |
| Fresh Issue Size (Amount) | up to ₹45.07 Cr | up to ₹37.41 Cr |
| OFS Issue Size | 11,00,400 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹10.56 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,94,800 shares | 21,88,000 shares |
| Issue Size Total (Amount) | up to ₹55.63 Cr | up to ₹37.41 Cr |
Influx Healthtech IPO opens on Jun 18, 2025, while Taurian MPS IPO opens on Sep 09, 2025. The closing date of Influx Healthtech IPO and Taurian MPS IPO is Jun 20, 2025, and Sep 11, 2025, respectively.
| Influx Healthtech IPO | Taurian MPS IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2025 | Sep 04, 2025 |
| Issue Open | Jun 18, 2025 | Sep 09, 2025 |
| Issue Close | Jun 20, 2025 | Sep 11, 2025 |
| Basis Of Allotment (Tentative) | Jun 23, 2025 | Sep 12, 2025 |
| Initiation of Refunds (Tentative) | Jun 24, 2025 | Sep 15, 2025 |
| Credit of Share (Tentative) | Jun 24, 2025 | Sep 15, 2025 |
| Listing date (Tentative) | Jun 25, 2025 | Sep 16, 2025 |
| Anchor Lockin End date 1 | Jul 23, 2025 | Oct 11, 2025 |
| Anchor Lockin End date 2 | Sep 21, 2025 | Dec 10, 2025 |
Influx Healthtech IPO P/E ratio is 13.04, as compared to Taurian MPS IPO P/E ratio of 11.29.
| Influx Healthtech IPO | Taurian MPS IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Influx Healthtech Ltd.'s revenue increased by 5% and profit after tax (PAT) rose by 19% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Taurian MPS Ltd.'s revenue increased by 67% and profit after tax (PAT) dropped by 16% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.85 | 88.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | 63.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.04 | 11.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹222.24 Cr. | ₹151.90 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.98% | 35.44% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 49.17% | 31.64% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.01 | 0.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.36 | ₹15.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.98% | 27.69% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Influx Healthtech IPO Retail Individual Investors (RII) are offered 20,29,200 shares while in Taurian MPS IPO retail investors are offered 20,29,200 shares. Qualified Institutional Buyers (QIB) are offered 11,59,200 shares in Influx Healthtech IPO and 4,36,800 shares in Taurian MPS IPO.
| Influx Healthtech IPO | Taurian MPS IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,36,400 shares | 6,55,200 shares |
| Market Maker Reservation | 3,06,000 shares | 2,99,200 shares |
| QIB | 11,59,200 shares | 4,36,800 shares |
| NII | 8,70,000 shares | 3,29,600 shares |
| RII | 20,29,200 shares | 7,66,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 57,94,800 shares | 21,88,000 shares |
Influx Healthtech IPO subscribed 201.35x in total, whereas Taurian MPS IPO subscribed 11.69x.
| Influx Healthtech IPO | Taurian MPS IPO | |
|---|---|---|
| QIB (times) | 137.87x | 15.89x |
| NII (times) | 481.10x | 17.37x |
| Big NII (times) | 21.39x | |
| Small NII (times) | 9.30x | |
| RII (times) | 117.68x | 6.86x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 201.35x | 11.69x |
